FDA Approved: EVENITY — Original Application (Amgen, Inc)

View source ↗

Summary

FDA approved Amgen's romosozumab-aqqg (Evenity) for the treatment of osteoporosis in postmenopausal women at high risk for fracture. This entry documents the or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Evenity (romosozumab)

Snippet

ORIG AP for EVENITY (ROMOSOZUMAB-AQQG)